Delta Financial Group’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$628K Hold
1,482
0.14% 114
2024
Q4
$613K Buy
1,482
+4
+0.3% +$1.75K 0.14% 109
2024
Q3
$747K Buy
1,478
+1
+0.1% +$486 0.28% 52
2024
Q2
$720K Buy
1,477
+5
+0.3% +$2.51K 0.3% 47
2024
Q1
$795K Buy
1,472
+50
+4% +$27.3K 0.23% 76
2023
Q4
$789K Hold
1,422
0.25% 74
2023
Q3
$622K Sell
1,422
-50
-3% -$24.9K 0.21% 81
2023
Q2
$739K Hold
1,472
0.87% 35
2023
Q1
$736K Hold
1,472
0.29% 61
2022
Q4
$596K Buy
+1,472
New +$571K 0.26% 74

Other funds holding IDXX

Delta Financial Group's IDXX Position: Q1 2025 in Review

Delta Financial Group held its Idexx Laboratories (IDXX) position steady in Q1 2025 at 1,482 shares worth $628K. The position accounts for 0.14% of the portfolio, ranked #114.

Delta Financial Group first reported a position in IDXX in Q4 2022 and has held it in 10 quarters since. The position peaked at $795K in Q1 2024. 1,142 funds tracked by Wall St. Rank hold IDXX as of Q1 2025.

  • Delta Financial Group held 1,482 shares of Idexx Laboratories worth $628K as of Q1 2025.
  • Delta Financial Group left its Idexx Laboratories share count unchanged in Q1 2025.
  • Idexx Laboratories made up 0.14% of Delta Financial Group's portfolio in Q1 2025, its #114 holding.
  • Delta Financial Group first reported a position in Idexx Laboratories in Q4 2022 and has held it in 10 quarters since.
  • Delta Financial Group's Idexx Laboratories position peaked at $795K in Q1 2024.
  • 1,142 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2025.

Based on Delta Financial Group's 13F filing for Q1 2025, filed 9 May 2025.